The effects of fampridine on eye movements in multiple sclerosis patients with internuclear ophthalmoplegia

Autor: Kanhai, K, Wagenaar, Y L, Nij-Bijvank, J A, Klaassen, E S, Lim, K, Ber-Gheanu, S C, Petzold, A, Verma, A, Rijn, R, Groeneveld, G

Publikováno v: Clinical Pharmacology & Therapeutics, 101, S32-S33. Wiley-Blackwell
Kanhai, K, Wagenaar, Y L, Nij-Bijvank, J A, Klaassen, E S, Lim, K, Ber-Gheanu, S C, Petzold, A, Verma, A, Rijn, R & Groeneveld, G 2017, ' The effects of fampridine on eye movements in multiple sclerosis patients with internuclear ophthalmoplegia ', Clinical Pharmacology & Therapeutics, vol. 101, pp. S32-S33 . < http://www.mendeley.com/research/effects-fampridine-eye-movements-multiple-sclerosis-patients-internuclear-ophthalmoplegia >

BACKGROUND: Internuclear ophthalmoplegia (INO) is a common cause of visual symptoms in patients with multiple sclerosis (MS). It is characterized by slowing eye adduction during horizontal saccades. Recent studies suggest fampridine may improve nerve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::18ae965da48598b1ee98483699107533
https://research.vumc.nl/en/publications/605f9a0f-9ce0-4c0d-b2f6-f98aba9f6095